Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

Clinical trial NCT03454750 · COMPLETED

Trial details

NCT number: NCT03454750
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer 68Ga-PSMA PET/CT Positive

Start date: 2022-10-25
Primary completion: 2024-05-22
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.